News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Backs Nycomed's Daxas In Deadly Lung Disease; Drug Approval Could Spur Nycomed IPO



7/6/2010 7:47:01 AM

ZURICH July 6 (Reuters) - Nycomed's [NYCMD.UL] lung drug Daxas has won European Union backing to treat patients with chronic obstructive pulmonary disease, bringing to market the first new type of treatment for the disease in over a decade.

Read at Wall Street Journal
Read at Reuters


comments powered by Disqus
Nycomed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES